The Food and Drug Administration (FDA) has expanded the approval of Evkeeza ® (evinacumab-dgnb) to include children aged 1 year and older with homozygous familial hypercholesterolemia (HoFH).

The Pentagon said it would forbid reporters from gathering any information that had not been authorized for release, and ...

Pediatric dosing expected to begin in Q4 2025Pivotal cohort expected to begin enrolling in Q1 2026BLA submission anticipated in early 2028Part A ...

As we see this through Daniel’s eyes, implementation details regarding addressing often reveal fundamental design constraints ...

This demand is commonly referred to as urgent order processing. In the Zhangzhou area, when enterprises face tight product ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...

Topline results were announced from a phase 3 trial evaluating tirzepatide in pediatric patients with type 2 diabetes inadequately controlled with metformin, basal insulin, or both.

On September 10, 2025, the U.S. Department of Defense (DoD) published a final rule that will shake up cybersecurity ...

TREMFYA® offers the flexibility of self-administration from the start of treatment, building on the prior approval of ...

Corruption in public spending isn’t an abstraction for Filipinos; we see it every time a “completed” project turns out to be a patch of mud or a slab that cracks after the first rain. This year’s ...

Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine ...

Peer reviewers judge the validity and quality of new research. These judgements would ideally be impartial, but some reviewers may give a more favourable review if they are cited in the article ...